Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal dexmedetomidine versus sufentanil added to bupivacaine for knee prosthesis spinal anesthesia
IRCT20141001019359N12Phase 3Completed
- Sponsor
- North Khorasan University of Medical Sciences
- Start
- May 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Dexmedetomidine + bupivacaine, Sufentanil + bupivacaine and Bupivacaine alone (3 arms). Primary endpoints: Level of analgesia and Duration of analgesia. Started May 2022; status: completed.
02
Drugs
dexmedetomidinesufentanilbupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20141001019359N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141001019359N12.